Hereditary angioedema: treatment, management, and precautions in patients presenting for dental care

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 109, Issue 2, 2010, Pages 168-172

  Van Sickels, Nicholas J ^a   Hunsaker, Robert B ^b   Van Sickels, Joseph E ^b  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; ANDROGEN; ANTIESTROGEN; ANTIFIBRINOLYTIC AGENT; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT INHIBITOR; SERPING1 PROTEIN, HUMAN; TRANEXAMIC ACID;

ACUTE DISEASE; ADULT; AIRWAY OBSTRUCTION; ANGIONEUROTIC EDEMA; CASE REPORT; CHRONIC DISEASE; DENTAL CARE; FEMALE; GENETICS; HUMAN; LARYNX EDEMA; MIDDLE AGED; PATHOLOGY; PLASMA; REVIEW;

6-AMINOCAPROIC ACID; ACUTE DISEASE; ADULT; AIRWAY OBSTRUCTION; ANDROGENS; ANGIOEDEMAS, HEREDITARY; ANTIFIBRINOLYTIC AGENTS; CHRONIC DISEASE; COMPLEMENT C1 INACTIVATOR PROTEINS; COMPLEMENT C1 INHIBITOR PROTEIN; COMPLEMENT INACTIVATING AGENTS; DENTAL CARE FOR CHRONICALLY ILL; ESTROGEN ANTAGONISTS; FEMALE; HUMANS; LARYNGEAL EDEMA; MIDDLE AGED; PLASMA; TRANEXAMIC ACID;

EID: 74049158675     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2009.09.031     Document Type: Review

References (29)

1. Frank M.M. Hereditary angioedema. J Allergy Clin Immunol 121 (2008) S398-S401
2. Nzeako U.C., Frigas E., and Tremaine W.J. Hereditary angioedema: a broad review for clinicians. Arch Intern Med 161 (2001) 2417-2429
3. Bork K., and Barnstedt S.E. Laryngeal edema and death from asphyxiation after tooth extraction in four patients with hereditary angioedema. J Am Dent Assoc 134 (2003) 1088-1094
4. Nagler R., Muska E., and Laster Z. Induced acute hereditary angioedema: a life-threatening condition. J Oral Maxillofac Surg 66 (2008) 1287-1289
5. Rice S., Cochrane T.J., Millwaters M., and Ali N.T. Emergency management of upper airway angio-oedema after routine dental extraction in a patient with C1 esterase deficiency. Br J Oral Maxillofac Surg 46 (2008) 394-396
6. Epstein S. Jury awards $11 M to Woodbridge family in oral surgery malpractice case. New Jersey Real-Time News (March 6, 2009)
7. Turner M.D., Oughourli A., Heaney K., and Selvaggi T. Use of recombinant plasma kallikrein inhibitor in hereditary angioedema: a case report and review of the management of the disorder. J Oral Maxillofac Surg 62 (2004) 1553-1556
8. Maeda S., Miyawaki T., Nomura S., Yagi T., and Shimada M. Management of oral surgery in patients with hereditary or acquired angioedemas: review and case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96 (2003) 540-543
9. Tricker N.D., Malone K.M., and Ellis M.M. Hereditary angioedema: a case report and literature review. Gen Dent 50 (2002) 540-543
10. Aziz S.R., and Tin P. Spontaneous angioedema of oral cavity after dental impressions. N Y State Dent J 68 (2002) 42-45
11. Farkas H., Gyeney L., Gidófalvy E., Füst G., and Varga L. The efficacy of short-term danazol prophylaxis in hereditary angioedema patients undergoing maxillofacial and dental procedures. J Oral Maxillofac Surg 57 (1999) 404-408
12. Karlis V., Glickman R.S., Stern R., and Kinney L. Hereditary angioedema: case report and review of management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 83 (1997) 462-464
13. Peled M., Ardekian L., Schnarch A., and Laufer D. Preoperative prophylaxis for C1 esterase-inhibitor deficiency in patients undergoing oral surgery: a report of three cases. Quintessence Int 28 (1997) 169-171
14. Atkinson J.C., and Frank M.M. Oral manifestations and dental management of patients with hereditary angioedema. J Oral Pathol Med 20 (1991) 139-142
15. Crosher R. Intravenous tranexamic acid in the management of hereditary angio-oedema. Br J Oral Maxillofac Surg 25 (1987) 500-506
16. Albright B.W., and Taylor C.G. Hereditary angioneurotic edema: report of case. J Oral Surg 37 (1979) 888-890
17. Delfino J.J., Sclaroff A., Giglio J.A., and Travis M. Management of a patient with hereditary angioneurotic edema. J Oral Surg 36 (1978) 890-892
18. Austen K.F. Allergies, anaphylaxis, and systemic mastocytosis. In: Fauci A.S., Braunwald E., Kasper D.L., Hauser S.L., Longo D.L., Jameson J.L., and Loscalzo J. (Eds). Harrison's principles of internal medicine. 17th ed. (2008), McGraw-Hill, New York 2061-2070
19. Kaplan A.P. Urticaria and angioedema. In: Adkinson Jr. N.F., Bochner B.S., Busse W.W., Holgate S., Lemanske Jr. R., and Simons F.E. (Eds). Adkinson: Middleton's allergy: principles and practice. 7th ed. (2008), Mosby, St. Louis 1073-1074
20. Zuraw B.L. Clinical practice. Hereditary angioedema. N Engl J Med 359 (2008) 1027-1036
21. Davis III A.E. Mechanism of angioedema in first complement component inhibitor deficiency. Immunol Allergy Clin North Am 26.4 (2006) 633-651
22. Frank M.M., Gelfan J.A., and Atkinson J.P. Hereditary angioedema: the clinical syndrome and its management. Ann Internal Med 84 (1976) 580-593
23. Vleeming W., van Amsterdam J.G., Stricker B.H., and de Wildt D.J. ACE inhibitor-induced angioedema. Incidence, prevention and management. Drug Saf 18 (1998) 171-188
24. Prematta M., Gibbs J.G., Pratt E.L., Stoughton T.R., and Craig T.J. Fresh frozen plasma for the treatment of hereditary angioedema. Ann Allergy Asthma Immunol 98 (2007) 383-388
25. Agostoni A., Aygören-Pürsün E., Binkley K.E., Blanch A., Burk K., et al. Hereditary and acquired angioedema: problems and progress: proceedings of the third C1-esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol 114 3 Suppl (2004) S51-S131
26. Riedl C.T., Dykewicz M.S., Gower R.G., Baker J., Edelman F.J., Hurewittz D., et al. When is prophylaxis for hereditary angioedema necessary?. Ann Allergy Asthma Immunol 102 (2009) 366-372
27. Epstein T.G., and Berstein J.A. Current and emerging management options for hereditary angioedema in the US. Drugs 68 (2008) 2561-2573
28. Reboldi G., Gentile G., Angeli F., and Verdecchia P. Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials. Vasc Health Risk Manag 5 (2009) 411-427
29. Komers R., and Anderson S. Are angiotensin-converting enzymes the best treatment of hypertension in type 2 diabetes?. Curr Opin Nephrol Hypertens 9 (2000) 173-179